Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating substance abuse in schizophrenia. An initial report.

M E Bennett1, A S Bellack, J S Gearon

  • 1Department of Psychiatry, University of Maryland School of Medicine and VA Capital Network Mental Illness Research, Education, and Clinical Center, Baltimore, Maryland 21201, USA. mbenn002@umaryland.edu

Journal of Substance Abuse Treatment
|April 18, 2001
PubMed
Summary

This study updates the Behavioral Treatment for Substance Abuse in Schizophrenia (BTSAS) program for patients with schizophrenia and co-occurring substance use disorders. Clinical experience and outcome data are presented to guide treatment improvements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychosocial treatment in schizophrenia.

Dialogues in clinical neuroscience·2011
Same author

Synthesis of a new element with atomic number Z = 117.

Physical review letters·2010
Same author

Chronic wounds and the medical biofilm paradigm.

Journal of wound care·2010
Same author

Polybrominated diphenyl ethers in two species of marine top predators from England and Wales.

Chemosphere·2002
Same author

Interpersonal control and expressed emotion in families of persons with schizophrenia: change over time.

Schizophrenia bulletin·2002
Same author

Measuring orthodontic treatment satisfaction: questionnaire development and preliminary validation.

Journal of public health dentistry·2001

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Addiction Medicine

Background:

  • Schizophrenia is frequently comorbid with substance use disorders (SUDs).
  • Neurocognitive and social deficits in schizophrenia impede SUD treatment efficacy.
  • Existing SUD treatments often require adaptation for this population.

Purpose of the Study:

  • To provide an update on the Behavioral Treatment for Substance Abuse in Schizophrenia (BTSAS) program.
  • To discuss clinical experience and program evolution over five years.
  • To present preliminary outcome data for patients with schizophrenia and SUDs.

Main Methods:

  • The BTSAS program was adapted and implemented.
  • Attendance, participation, and substance use data were collected.

Related Experiment Videos

  • Outcome data were analyzed for patients completing the program, comparing good and poor progress groups.

    • Main Results:

    • Data presented for 42 patients who consented, 14 who completed, and 14 who dropped out.
    • Outcome data analyzed for 14 patients.
    • Comparison between good progress (n=5) and poor progress (n=9) patients based on urine test results.

    Conclusions:

    • The BTSAS program has undergone five years of development and adaptation.
    • Clinical experience provides insights into treatment delivery for schizophrenia and SUDs.
    • Further implications for optimizing treatment strategies are discussed.